XGEN PHARMS FDA Approval ANDA 076923

ANDA 076923

XGEN PHARMS

FDA Drug Application

Application #076923

Application Sponsors

ANDA 076923XGEN PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 0.01MG BASE/ML0LIOTHYRONINE SODIUMLIOTHYRONINE SODIUM

FDA Submissions

ORIG1AP2005-08-17

TE Codes

001PrescriptionAP

CDER Filings

XGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 76923
            [companyName] => XGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"LIOTHYRONINE SODIUM","activeIngredients":"LIOTHYRONINE SODIUM","strength":"EQ 0.01MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LIOTHYRONINE SODIUM","submission":"LIOTHYRONINE SODIUM","actionType":"EQ 0.01MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.